Cell and Gene Therapy, Industry
May 9, 2022
Via: FierceBiotechAspen Neuroscience, a biotech developing the first autologous neuron replacement for Parkinson’s disease, is seeing double, as investors have flooded the company’s series B with $147.5 million following an initial $70 million round two years ago. The private neurodegenerative disease […]
July 19, 2024
July 11, 2024
July 11, 2024